Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02487459
Title Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bellicum Pharmaceuticals
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field